Published: 2 December 2021
Publications
Quarterly summary of recent safety communications
Published: 2 December 2021
Prescriber Update 42(4): 59
December 2021
The table below is a summary of recent safety communications to health care professionals and consumers, published on the Medsafe website.
Date | Communication | Topic |
---|---|---|
COVID-19 | Adverse events following immunisation with COVID-19 vaccines | |
17/11/2021 | Monitoring | Menstrual disorders and unexpected vaginal bleeding – Comirnaty (Pfizer COVID-19 vaccine) |
17/11/2021 | Monitoring | COVID-19 vaccination in pregnancy: no safety concerns with Comirnaty (Pfizer COVID-19 vaccine) |
15/11/2021 | Alert | Consent to distribute medicines containing bufexamac was revoked on 9 November 2021 |
21/10/2021 | Dear Healthcare Professional Letter | Supply of Actemra (tocilizumab) 162 mg/0.9 mL solution for subcutaneous (PDF, 4 pages, 753 KB) |
11/10/2021 | Dear Healthcare Professional Letter | Supply of Actemra (tocilizumab) for hospital use (PDF, 4 pages, 753 KB) |
06/09/2021 | Dear Healthcare Professional Letter | Notification of temporary supply shortage for Actemra (tocilizumab) (PDF, 2 pages, 215 KB) |
06/09/2021 | Alert | Risks of importing or prescribing ivermectin for prevention or treatment of COVID-19 |